ASA, S. Et Al. 2023. Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance. Nuclear Medicine Communications , vol.44, no.1 , 65-73.

ASA, S., Ozgur, E., Uslu-Besli, L., İNCE, B., Sager, S., Demirdag, C., ... Guner, E.(2023). Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance. Nuclear Medicine Communications , vol.44, no.1, 65-73.

ASA, SERTAÇ Et Al. "Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance," Nuclear Medicine Communications , vol.44, no.1, 65-73, 2023

ASA, SERTAÇ Et Al. "Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance." Nuclear Medicine Communications , vol.44, no.1, pp.65-73, 2023

ASA, S. Et Al. (2023) . "Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance." Nuclear Medicine Communications , vol.44, no.1, pp.65-73.

@article{article, author={SERTAÇ ASA Et Al. }, title={Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance}, journal={Nuclear Medicine Communications}, year=2023, pages={65-73} }